News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER at mid-year: 2026 progress and what’s ahead
In 2026 so far, RECOVER has published new research findings across nearly all its different studies and will soon be enrolling participants for the next phases of the adult observational study and clinical trials.
Feature
173 Results
173 Results
R3 Seminar Recap: Vascular Pathophysiology of PASC
During the December 13th RECOVER Research Review (R3) Seminar, researchers presented on the vascular pathophysiology of PASC, exploring how blood vessel dysfunction might contribute to long-term effects following COVID-19 infection.
R3 Seminar Recap
R3 Seminar Recap: Understanding the Biomarkers of PASC
During the November 8th RECOVER Research Review (R3) Seminar, researchers presented their understanding of the biomarkers of PASC. Presenters discussed the need for biomarkers, early immunological findings, ultrasensitive viral antigen measurements, and markers of fungal translocation.
R3 Seminar Recap
RECOVER program takes first steps in advancing toward clinical trials to better understand Long COVID
RECOVER will launch several clinical trials to find treatments for five of the most burdensome symptom clusters identified by people suffering from Long COVID.
Announcement
R3 Seminar Recap: Frequency and Burden of Symptoms Following SARS-CoV-2 Infection
During the October 25th RECOVER Research Review (R3) Seminar, researchers presented on how symptoms following SARS-CoV-2 infection have been measured, the importance of understanding the scope of symptoms, and patient perception about the burden of various symptoms. Presenters discussed the development and validation of a symptom burden questionnaire, methods to assess symptoms among RECOVER adult cohort participants, and the development of a questionnaire to capture symptoms and their burdensomeness after COVID infection.
R3 Seminar Recap
R3 Seminar Recap: Leveraging Mobile Health Platform Technologies to Understand PASC
During the October 11th RECOVER Research Review (R3) Seminar, presenters discussed leveraging mobile health platform technologies to understand PASC. The seminar explored what is known about these technologies in PASC research, the gaps in our knowledge, and how RECOVER will contribute to filling these gaps.
R3 Seminar Recap
R3 Seminar Recap: SARS-CoV-2 Infection: Findings from Autopsy Studies
During the September 27th RECOVER Research Review (R3) Seminar, researchers presented findings from autopsy studies on PASC. Presenters discussed what has been learned about PASC from autopsy studies, the gaps in our knowledge, and how RECOVER will contribute to filling these knowledge gaps.
R3 Seminar Recap
R3 Seminar Recap: Clinical Spectrum of PASC: Focus on Coagulopathies
During the September 13th RECOVER Research Review (R3) Seminar, researchers presented on the clinical spectrum of PASC with a focus on coagulopathies. Presenters discussed our current understanding of coagulopathies in PASC, the gaps in our knowledge, and how RECOVER will contribute to filling these knowledge gaps.
R3 Seminar Recap
R3 Seminar Recap: Clinical Spectrum of PASC: Focus on Sleep
During the August 23rd RECOVER Research Review (R3) Seminar, researchers presented on the clinical spectrum of PASC with a focus on sleep. Presenters discussed our current understanding of sleep disturbances in PASC patients, the gaps in our knowledge, and how RECOVER will contribute to filling these knowledge gaps.
R3 Seminar Recap